1061 related articles for article (PubMed ID: 17075228)
1. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
Picken MM
Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
[TBL] [Abstract][Full Text] [Related]
2. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
Comenzo RL
Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
[TBL] [Abstract][Full Text] [Related]
3. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
Nasr SH; Said SM; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Dispenzieri A; Buadi FK; Vrana JA; Theis JD; Dogan A; Leung N
Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
[TBL] [Abstract][Full Text] [Related]
4. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report.
Miyazaki D; Yazaki M; Gono T; Kametani F; Tsuchiya A; Matsuda M; Takenaka Y; Hosh Y; Ikeda S
Amyloid; 2008 Jun; 15(2):125-8. PubMed ID: 18484339
[TBL] [Abstract][Full Text] [Related]
5. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
6. [Systemic amyloidoses in renal biopsy samples].
Bauerová L; Honsová E; Rysavá R; Povýsil C
Cesk Patol; 2009 Jul; 45(3):64-8. PubMed ID: 19764159
[TBL] [Abstract][Full Text] [Related]
7. [Immunoglobulin light chain amyloidosis: recent molecular, clinical and therapeutic approach].
Thierry A; Bridoux F; Goodman H; Belmouaz S; Abou Ayache R; Desport E; Jaccard A; Touchard G
Nephrologie; 2004; 25(4):111-8. PubMed ID: 15291138
[TBL] [Abstract][Full Text] [Related]
8. Renal granular monoclonal light chain deposits: morphological aspects in 11 cases.
Noel LH; Droz D; Ganeval D; Grunfeld JP
Clin Nephrol; 1984 May; 21(5):263-9. PubMed ID: 6428790
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease.
Buxbaum J
Hematol Oncol Clin North Am; 1992 Apr; 6(2):323-46. PubMed ID: 1582976
[TBL] [Abstract][Full Text] [Related]
10. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
[TBL] [Abstract][Full Text] [Related]
11. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease.
Kaplan B; Ramirez-Alvarado M; Sikkink L; Golderman S; Dispenzieri A; Livneh A; Gallo G
Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171
[TBL] [Abstract][Full Text] [Related]
12. Screening and differential diagnosis of renal light chain-associated diseases.
Gerth J; Sachse A; Busch M; Illner N; Muegge LO; Gröne HJ; Wolf G
Kidney Blood Press Res; 2012; 35(2):120-8. PubMed ID: 22056791
[TBL] [Abstract][Full Text] [Related]
13. New insights into systemic amyloidosis: the importance of diagnosis of specific type.
Picken MM
Curr Opin Nephrol Hypertens; 2007 May; 16(3):196-203. PubMed ID: 17420662
[TBL] [Abstract][Full Text] [Related]
14. Light-chain (AL) amyloidosis: diagnosis and treatment.
Sanchorawala V
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1331-41. PubMed ID: 17699366
[TBL] [Abstract][Full Text] [Related]
15. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary light chain deposition disease: report of five cases and review of the literature.
Bhargava P; Rushin JM; Rusnock EJ; Hefter LG; Franks TJ; Sabnis SG; Travis WD
Am J Surg Pathol; 2007 Feb; 31(2):267-76. PubMed ID: 17255772
[TBL] [Abstract][Full Text] [Related]
17. Heavy-chain amyloidosis in TGFBI-negative and gelsolin-negative atypical lattice corneal dystrophy.
Pradhan MA; Henderson RA; Patel D; McGhee CN; Vincent AL
Cornea; 2011 Oct; 30(10):1163-6. PubMed ID: 21743312
[TBL] [Abstract][Full Text] [Related]
18. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease.
Kaplan B; Livneh A; Gallo G
Br J Haematol; 2007 Mar; 136(5):723-8. PubMed ID: 17223908
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region.
Hoshii Y; Kiyama M; Cui D; Kawano H; Ishihara T
Pathol Int; 2006 Jun; 56(6):324-30. PubMed ID: 16704496
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition.
Sanders PW; Herrera GA; Kirk KA; Old CW; Galla JH
Lab Invest; 1991 Apr; 64(4):527-37. PubMed ID: 1901926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]